Intravesical therapy for bladder cancer
- 1 February 2000
- Vol. 55 (2) , 161-168
- https://doi.org/10.1016/s0090-4295(99)00463-x
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancerBritish Journal of Cancer, 1998
- A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-GuerinJournal of Urology, 1996
- Intravesical Bacillus Calmette-Guerin Immunoprophylaxis of Superficial Bladder Cancer: Results of a Controlled Prospective Trial with Modified Treatment ScheduleJournal of Urology, 1993
- Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerinUrology, 1991
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor ActivityJournal of Urology, 1987
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- Experience with intravesical bacillus calmette-guèrin therapy of superficial bladder tumorsUrology, 1985